Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancer
卵巢癌适应性化疗（ACTOv）研究方案：一项多中心II期随机对照试验，旨在评估基于CA125变化的卡铂适应性化疗（AT）对复发性铂敏感高级别浆液性或高级别子宫内膜样卵巢癌患者的疗效。
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-091262
Mukherjee, Uma Anne; Hockings, Helen; Counsell, Nicholas; Patel, Apini; Narayanan, Priya; Wilkinson, Katie; Dhanda, Harjot; Robinson, Kathy; McNeish, Iain; Anderson, Alexander R A; Miller, Rowan; Gourley, Charlie; Graham, Trevor; Lockley, Michelle
